Sep 29

SS 27 - Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials

238 - Targeting Recurrent Glioblastoma with Stereotactic Radiosurgery and Tumor Treating Fields Guided by 18F-FET-PET: Long-Term Results from a Prospective Phase 2 Trial (TTaRGeT)

12:40pm - 12:50pm ET

Presenter(s)

Maciej Harat, MD, PhD - Franciszek Lukaszczyk Oncology Center, Bydgoszcz,